Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT

Abstract

Background Major depressive disorder represents (MDD) a major cause of disability and disease burden. Beside antidepressant medication, psychotherapy is a key approach of treatment. Schema therapy has been shown to be effective in the treatment of psychiatric disorders, especially personality disorders, in a variety of settings and patient groups. Nevertheless, there is no evidence on its effectiveness for MDD in an inpatient nor day clinic setting and little is known about the factors that drive treatment response in such a target group. Methods In the current protocol, we outline OPTIMA (OPtimized Treatment Identification at the MAx Planck Institute): a single-center randomized controlled trial of schema therapy as a treatment approach for MDD in an inpatient and day clinic setting. Over the course of 7 weeks, we compare schema therapy with cognitive behavioral therapy and individual supportive therapy, conducted in individual and group sessions and with no restrictions regarding concurrent antidepressant medication, thus approximating real-life treatment conditions. N = 300 depressed patients are included. All study therapists undergo a specific training and supervision and therapy adherence is assessed. Primary outcome is depressive symptom severity as self-assessment (Beck Depression Inventory-II) and secondary outcomes are clinical ratings of MDD (Montgomery-Asberg Depression Rating Scale), recovery rates after 7 weeks according to the Munich-Composite International Diagnostic Interview, general psychopathology (Brief Symptom Inventory), global functioning (World Health Organization Disability Assessment Schedule), and clinical parameters such as dropout rates. Further parameters on a behavioral, cognitive, psychophysiological, and biological level are measured before, during and after treatment and in 2 follow-up assessments after 6 and 24 months after end of treatment. Discussion To our knowledge, the OPTIMA-Trial is the first to investigate the effectiveness of schema therapy as a treatment approach of MDD, to investigate mechanisms of change, and explore predictors of treatment response in an inpatient and day clinic setting by using such a wide range of parameters. Insights from OPTIMA will allow more integrative approaches of psychotherapy of MDD. Especially, the identification of intervention-specific markers of treatment response can improve evidence-based clinical decision for individualizing treatment. Trial registration Identifier on clinicaltrials.gov: NCT03287362; September, 12, 2017

Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders

“…Burden of psychiatric disease. Participants underwent a modified version of the computer-based Munich-Composite International Diagnostic Interview (M-CIDI) (DIA-X/M-CIDI, [44]) conducted by trained study assistants (details in [38,39]) to asses current (last four weeks) or past lifetime DSM-IV diagnosis [45]. Individuals could fulfill criteria for no, subthreshold or full diagnoses.…”

Stress-induced brain responses are associated with BMI in women

“…Five participants had to be excluded due to insufficient saliva volume at T6. For a subset of the BeCOME study (n=198) cytokine assays were measured together with samples from a second in-house study (Kopf-Beck et al, 2020). Blood was collected in Sarstedt plasma tubes at 8.15am in a fasted state and frozen at -80° C after centrifugation and aliquotating.…”

Group Schema Therapy for Reducing Parenting Stress in Families with Children with Disabilities

“…Имеются данные об эффективности групповой схема-терапии для пожилых пациентов с расстройствами настроения [37], в работе с избегающим расстройством личности [38] и нервной анорексией [39]. Схема-терапия использует более широкий инструментарий для работы с родителями, чем распространенные программы, ориентированные на изменение поведения родителя по отношению к ребенку и обучение родителя навыкам ухода и воспитания [40]. Схема-терапия направлена не только на развитие родительских навыков, но и на обучение родителей удовлетворению своих эмоциональных потребностей и регулированию уровня стресса.…”

“…1 По данным множества специалистов, при неудовлетворении эмоциональных потребностей у людей начинают проявляться психопатологические симптомы (в т. ч. симптомы стресса) [40]. Если базовые эмоциональные потребности не удовлетворяются, то у человека формируются схемы.…”